ARCHIVES

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004